Our study identifies TRIM21 as a negative regulator of liver steatosis in NASH and provides mechanistic insights into an immunometabolic crosstalk that limits fatty acid synthesis and fructose metabolism during metabolic stress. This evidence concerns the gene TRIM21 and metabolic dysfunction-associated steatohepatitis.